top of page
Search Results

437 items found for "receptor binding"

  • Posttranslational modifications in GPCR internalization

    August 2022 "G protein-coupled receptors (GPCRs) are the largest family of membrane receptors that serve Classically, GPCR internalization has been considered to lead to receptor desensitization. However, many studies over the past decade have reported that internalized membrane receptors can trigger The "internalized activation" provides a completely new understanding for the receptor internalization

  • 📰 GPCR Weekly News, June 19 to 25, 2023

    GPCR Activation and Signaling Stimulation of ectopically expressed muscarinic receptors induces IFN-γ Serotonin 5-HT7 receptor slows down the Gs protein: a single molecule perspective. Striatal mGlu5-mediated synaptic plasticity is independently regulated by location-specific receptor in vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human PAC1 Receptor GPCR Research A coiled-coil-based design strategy for the thermostabilization of G-protein-coupled receptors

  • GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...

    cycle with IGF1/IGF1R signaling pathway "There is a potential correlation between G-protein-coupled receptor-associated Mechanistically, GASP1 inhibited proteasomal degradation of insulin-like growth factor 1 receptor (IGF1R ) by competitively binding to IGF1R with ubiquitin E3 ligase MDM2, thereby activating its downstream

  • 📰 GPCR Weekly News, January 8 to 14, 2024

    Kathleen M Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in GPCR Ecosystem group, where you can find Dr. January 8th to 14th, 2024 Adhesion GPCRs Conformational transitions and activation of the adhesion receptor in auditory neurons GPCRs in Oncology and Immunology G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold

  • 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!

    Premium members enjoy a 5-day free trial—join now and save with the 25% OFF early bird discount . Take advantage of a 25% early bird discount for premium members! News  from August 19th to 25th, 2024 GPCR Activation and Signaling Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling GPCR Binders, Drugs, and more Selenomethionine knockout mice Methods & Updates in GPCR Research Genome-wide identification of 769 G protein-coupled receptor

  • 📰 GPCR Weekly News, March 6 to 12, 2023

    GPCR Binders, Drugs, and more Autoantibodies targeting G protein-coupled receptors: An evolving history Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery. Structural basis of peptide recognition and activation of endothelin receptors. PhD Studentship - Insight Into The Neuroprotective Function Of The Prostaglandin Receptor Ep2.

  • PI(4,5)P 2-stimulated positive feedback drives the recruitment of Dishevelled to Frizzled in Wnt-β-c

    September 2022 "In the Wnt-β-catenin pathway, Wnt binding to Frizzled (Fzd) and LRP5 or LRP6 (LRP5/6) co-receptors inhibits the degradation of the transcriptional coactivator β-catenin by recruiting the was not affected by Wnt ligands, in contrast to other members of the GPCR superfamily for which the binding Instead, Fzd-Dvl binding was enhanced by increased concentration of the lipid PI(4,5)P2, which is generated Moreover, binding to Fzd did not promote Dvl DEP domain dimerization, which has been proposed to be required

  • 📰 GPCR Weekly News, May 1 to 7, 2023

    GPCR Activation and Signaling Constitutive activity of the dopamine (D5 ) receptor, highly expressed Cholesterol Biases the Conformational Landscape of the Chemokine Receptor CCR3: A MAS SSNMR-Filtered intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2 G protein-coupled receptor GPCRs in Neuroscience GPCR interactions involving metabotropic glutamate receptors and their relevance G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders.

  • Comparative study of neuropeptide signaling systems in Hemiptera

    2022 "Numerous physiological processes in insects are tightly regulated by neuropeptides and their receptors form an ancient signaling system, there is still a great deal of variety in neuropeptides and their receptors Neuropeptides and their receptors have been documented in many hemipteran insects, but the differences Here, 33 neuropeptide precursors and 48 putative neuropeptide G protein-coupled receptor (GPCR) genes Independent secondary losses of the adipokinetic hormone/corazonin-related peptide receptor (ACP) and

  • 📰 GPCR Weekly News, April 17 to 23, 2023

    GPCR Activation and Signaling How can we improve the measurement of receptor signaling bias? The relaxin receptor RXFP1 signals through a mechanism of autoinhibition. Regulation of the pro-inflammatory G protein-coupled receptor GPR84. GPCR Binders, Drugs, and more Development of a 5-HT7 receptor antibody for the rat: the good, the bad GPCRs in Neuroscience G protein coupled receptors as targets for transformative neuropsychiatric therapeutics

  • Community guidelines for GPCR ligand bias: IUPHAR review 32

    Depending on which ligand activates a receptor, it can engage different intracellular transducers. 'biased signalling' paradigm requires that we now characterize physiological signalling not just by receptors but by ligand-receptor pairs. The guidelines will aid consistency and clarity, as the basic receptor research and drug discovery communities

  • Location bias contributes to functionally selective responses of biased CXCR3 agonists

    November 2022 "Some G protein-coupled receptor (GPCR) ligands act as "biased agonists" that preferentially contributes to the biased signaling generated by three endogenous ligands of the GPCR CXC chemokine receptor mouse model of contact hypersensitivity, β-arrestin-biased CXCR3-mediated inflammation is dependent on receptor overall biased response observed at CXCR3, which has important implications for drugs targeting chemokine receptors

  • Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization

    Specifically, we explore the role of actin cytoskeleton in regulating the dynamics of the serotonin1A receptor , a crucial neurotransmitter G protein-coupled receptor (GPCR) that plays a major role in the generation For this, we analyzed the lateral dynamics of the serotonin1A receptor in cholesterol-depleted cells Our results indicate that lateral diffusion parameters of serotonin1A receptors in normal cells are consistent Interestingly, these parameters are altered in cholesterol-depleted cells and the receptor exhibits dynamic

  • 📰 GPCR Weekly News, April 3 to 9, 2023

    GPCR Binders, Drugs, and more Inhibiting a promiscuous GPCR: iterative discovery of bitter taste receptor Sodium is a negative allosteric regulator of the ghrelin receptor. GPCRs in Cardiology, Endocrinology, and Taste Novel roles for G protein-coupled receptor kinases in cardiac GPCRs in Neuroscience G protein-coupled receptors (GPCRs) as Potential Therapeutics for Psychiatric Disorders Transcriptomic profiling of sex-specific olfactory neurons reveals subset-specific receptor expression

  • 📰 GPCR Weekly News, May 8 to 14, 2023

    GPCR Activation and Signaling Ligand-induced activation and G protein coupling of prostaglandin F2α receptor Plasma membrane preassociation drives β-arrestin coupling to receptors and activation. An allosteric modulator of the adenosine A1 receptor potentiates the antilipolytic effect in rat adipose Reviews, GPCRs, and more Recent Studies on Serotonin 5-HT2A Receptor Antagonists in Medicinal Chemistry Mechanism of Activation of the Visual Receptor Rhodopsin.

  • Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa

    These disorders are mainly related to the abnormalities in the rod G protein-coupled receptor (GPCR), stability and phototransduction processes that lead to progressive loss of retina function and eventually blindness Targeting rhodopsin with small molecule chaperones to improve the folding and stability of the mutant receptor

  • 📰 GPCR Weekly News, March 20 to 26, 2023

    The Wnt pathway protein Dvl1 targets Somatostatin receptor 2 for lysosome-dependent degradation. Loss of biased signaling at a G protein-coupled receptor in overexpressed systems. GPCR Binders, Drugs, and more A snake toxin as a theranostic agent for the type 2 vasopressin receptor Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor. GPCRs in Cardiology, Endocrinology, and Taste Green mamba peptide targets type-2 vasopressin receptor

  • 📰 GPCR Weekly News, November 6 to November 12, 2023

    You can find more details about the speakers on the Live Talks page, and make sure to mark your calendar GPCR Activation and Signaling Neuronal survival factor TAFA2 suppresses apoptosis through binding to /CREB/BCL2 signaling pathway Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors containing G proteins and lacks effect on signaling mediated by human neutrophil expressed formyl peptide receptors Molecular recognition of niacin and lipid-lowering drugs by the human hydroxycarboxylic acid receptor

  • GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...

    Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A2A Adenosine Receptor "Modulators of the G protein-coupled A2A adenosine receptor (A2AAR) have been considered promising agents Structural analysis revealed that the introduced thiophene modification restricted receptor conformational This approach can expand the repertoire of adenosine receptor antagonists that can be designed based

  • Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...

    We previously demonstrated that the G protein-coupled receptor (GPCR) arginine vasopressin receptor type1A AVPR1A is part of a family of GPCR's including arginine vasopressin receptor type 2 (AVPR2). found that castration-resistant cells produced AVP, the endogenous ligand for arginine vasopressin receptors These data indicate that the AVP/arginine vasopressin receptor signaling axis represents a promising

  • 📰 GPCR Weekly News

    GPCRs in Neuroscience Photopharmacological manipulation of amygdala metabotropic glutamate receptor mGlu4 in Oncology and Immunology Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors Stability. iORbase: a database for the prediction of the structures and functions of insect olfactory receptors Sosei Heptares' Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Deadline February 12, 2023 Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology

  • 📰 GPCR Weekly News, July 3 to 9, 2023

    GPCR Activation and Signaling G protein activation via chemokine (C-X-C motif) receptor 4 and α1b -adrenoceptor The G protein-coupled receptor GPRC5C is a saccharide sensor with a novel "off" response. GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs Molecular Dynamics and Machine Learning Study of Adrenaline Dynamics in the Binding Pocket of GPCR.

  • MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?

    August 2022 "Chemokines, a subgroup of cytokines along with their receptors, are involved in various C-X-C motif chemokine receptor 4 (CXCR4), a G-protein-coupled receptor (GPCR), has one identified natural

  • 📰 GPCR Weekly News, February 13 to 19, 2023

    dysostosis with alopecia results from ETAR gain-of-function mutations via allosteric effects on ligand binding GPCR Binders, Drugs, and more Novel targets for potential therapeutic use in Diabetes mellitus. Reviews, GPCRs, and more Single nucleotide variations encoding missense mutations in G protein-coupled receptors GPCR Function Quantitative analysis of sterol-modulated monomer-dimer equilibrium of the β1-adrenergic receptor OLINVYK Respiratory Physiology Study In Anesthesiology Neurocrine Biosciences discovers new muscarinic M4 receptor

  • 📰 GPCR Weekly News, February 6 to 12, 2023

    Isoform- and ligand-specific modulation of the adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder Methods & Updates in GPCR Research Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency. Development and Characterization of a Highly Selective Turn-On Fluorescent Ligand for β3-Adrenergic Receptor Quantitative analysis of sterol-modulated monomer-dimer equilibrium of the β1-adrenergic receptor by

  • 📰 GPCR Weekly News

    Gβγ signaling: mechanisms, functions, and therapeutic targets Constitutive activity of the dopamine receptor highly expressed in CA1 hippocampal neurons, selectively reduces CaV 3.2 and CaV 3.3 currents GPCR Binders Mass Spectrometry Reveals Activity-Modifying Phosphorylation Barcode in a Class C G Protein-Coupled Receptor Molecular Insights into GPCR Function Synergistic and Competitive Lipid Interactions in the Serotonin 1A Receptor Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology.

  • 📰 GPCR Weekly News, August 7 to 13, 2023

    Remember, the early-bird registration and Abstract submission deadline is September 8, and the final GPCR Activation and Signaling Tail engagement of arrestin at the glucagon receptor Gα protein signaling bias at 5-HT1A receptor GPCRs in Cardiology, Endocrinology, and Taste Gβγ-SNAP25 exocytotic brake removal adipocyte browning, and protects against diet-induced obesity GPCRs in Neuroscience The neuropeptide receptor

  • 📰 GPCR Weekly News, November 13 to 19, 2023

    Endosomal signaling via cAMP in parathyroid hormone (PTH) type 1 receptor biology β-arrestin1 is an E3 pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB2 receptor glomeruli in response to a high salt challenge in the Dahl SS rat GPCRs in Neuroscience Neurokinin-2 receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor NTR-1's Essential Therapeutics Welcomes Melissa Faris as Chief Business Officer Septerna: Revitalizing G-Protein Coupled Receptor

bottom of page